Related Experiment Video
Updated: Jul 19, 2025
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Engineered extracellular vesicles in female reproductive disorders
Mengxue Zhang1, Jie Xing1, Shijie Zhao1
1Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University, 20 Zhengdong Road, Zhenjiang, Jiangsu 212001, PR China; Institute of Reproductive Sciences, Jiangsu University, 20 Zhengdong Road, Zhenjiang, Jiangsu 212001, PR China; Department of Central Laboratory, The Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China.
Engineered extracellular vesicles (EVs) offer promising cell-free therapeutic strategies for reproductive disorders like PCOS and endometriosis. These nanoscale vesicles overcome natural limitations, advancing clinical applications in women
Area of Science:
- Biotechnology and Regenerative Medicine
- Reproductive Biology and Endocrinology
- Nanomedicine and Drug Delivery
Background:
- Extracellular vesicles (EVs) are nanoscale, cell-free particles involved in intercellular communication.
- EVs possess advantages over cellular therapies, including low immunogenicity and reduced risks of tumorigenicity and embolization.
- Their unique properties make EVs highly promising for diagnosing and treating various reproductive disorders.
Purpose of the Study:
- To review engineering strategies for extracellular vesicles (EVs).
- To explore the regulatory effects and mechanisms of engineered EVs on specific reproductive disorders.
- To discuss the application prospects of engineered EVs in reproductive medicine.
Main Methods:
- Literature review of current research on extracellular vesicle (EV) engineering.
- Analysis of studies detailing the impact of engineered EVs on reproductive conditions.
- Synthesis of information on the therapeutic potential and challenges of EV-based strategies.
Main Results:
- Engineering strategies significantly enhance the application potential of EVs, overcoming limitations of natural EVs.
- Engineered EVs demonstrate regulatory effects and specific mechanisms in treating premature ovarian insufficiency (POI), polycystic ovarian syndrome (PCOS), recurrent spontaneous abortion (RSA), intrauterine adhesion (IUA), and endometriosis (EMS).
- The review highlights the substantial progress in driving EVs toward clinical applications in reproductive health.
Conclusions:
- Engineered extracellular vesicles (EVs) represent a novel and promising therapeutic avenue for female reproductive disorders.
- Further research and development in EV engineering can overcome existing challenges and accelerate clinical translation.
- This work provides a foundation for innovative treatments targeting a range of gynecological and reproductive conditions.
